Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||||
| Cash income from operating activities | 467.86%644.81K | -79.80%113.55K | -18.61%562.17K | 133.44%690.72K | -61.24%295.89K | -22.46%763.34K | -6.13%984.44K | -41.12%1.05M | 1.78M |
| Cash paid | -119.46%-1.44M | 30.82%-656.95K | 2.83%-949.56K | -10.25%-977.17K | 20.05%-886.32K | 64.85%-1.11M | 28.55%-3.15M | 41.14%-4.41M | -7.5M |
| Other cash payments from operating activities | -38.87%1.5K | --2.45K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating cash flow | -46.66%-796.93K | -40.27%-543.4K | -35.24%-387.39K | 51.48%-286.45K | -71.03%-590.43K | 84.09%-345.22K | 35.54%-2.17M | 41.15%-3.37M | ---5.72M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | -1,958.56%-1.13M | 90.77%-55.03K | 76.81%-596.02K | -881.48%-2.57M | -89.63%328.87K | 91.98%3.17M | 74.81%1.65M | 124.08%945.13K | -3.92M |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | 213.77%469.0554 | -98.29%149.4908 | 524.24%8.74K | 92.44%-2.06K | ---27.23K |
| Net investment purchase and sale | -22,093.24%-1.09M | 100.83%4.97K | 76.81%-596.02K | -882.60%-2.57M | -89.65%328.4K | 93.00%3.17M | 139.66%1.64M | 158.66%685.74K | ---1.17M |
| Net other investing changes | ---40K | ---- | ---- | ---- | --0.9307 | ---- | ---- | 117.34%165.13K | ---952.38K |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | -1,958.56%-1.13M | 90.77%-55.03K | 76.81%-596.02K | -881.48%-2.57M | -89.63%328.87K | 91.98%3.17M | 74.81%1.65M | 124.08%945.13K | ---3.92M |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | 1.88M | 0 | -27.03%2.53M | 308.63%3.47M | -346.63%-1.66M | -117.11%-372.02K | -79.21%2.17M | 10.46M | |
| Net issuance payments of debt | ---- | ---- | ---- | ---9.53K | ---- | -753.79%-1.95M | -110.52%-228.65K | 512.35%2.17M | ---527.31K |
| Net common stock issuance | --1.88M | ---- | ---- | -26.75%2.54M | 1,092.94%3.47M | --290.59K | ---- | ---- | --10.98M |
| Net other financing activities | ---- | ---- | ---- | ---- | --0.9307 | ---- | ---143.38K | ---- | ---- |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | --1.88M | --0 | ---- | -27.03%2.53M | 308.63%3.47M | -346.63%-1.66M | -117.11%-372.02K | -79.21%2.17M | --10.46M |
| Net cash flow | |||||||||
| Beginning cash position | -19.69%2.44M | -24.45%3.04M | -7.35%4.02M | 240.55%4.34M | 1,012.91%1.27M | -88.62%114.54K | -16.92%1.01M | 173.36%1.21M | --443.03K |
| Current changes in cash | 90.96%-54.08K | 39.15%-598.43K | -200.76%-983.42K | -110.20%-326.98K | 175.06%3.2M | 231.07%1.17M | -262.05%-889.02K | -130.15%-245.55K | --814.51K |
| End cash Position | -2.22%2.39M | -19.69%2.44M | -24.30%3.04M | -10.39%4.01M | 250.05%4.48M | 992.12%1.28M | -87.86%117.18K | -23.22%965.5K | --1.26M |
| Free cash from | -46.66%-796.93K | -40.27%-543.4K | -35.24%-387.39K | 51.48%-286.45K | -71.03%-590.43K | 84.09%-345.22K | 35.62%-2.17M | 41.36%-3.37M | ---5.75M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |